微創醫療(00853.HK):上實資本領銜收購2.91億股股份 國資背景助力戰略升級
格隆匯7月25日丨微創醫療(00853.HK)發佈公吿,董事會已獲Otsuka Medical Devices Co., Ltd.(“賣方”,於本公吿日期為公司主要股東,連同其股東,統稱“大冢”)吿知,2025年7月25日,賣方訂立若干買賣協議,據此,賣方有條件同意向若干買方出售合共約2.91億股公司股份,於各情況下,均須遵守該等協議各自的條款及條件。買方包括上海上實資本管理有限公司(“上實資本”)旗下的基金、We’Tron Capital Limited(於本公吿日期為公司主要股東)及公司管理層的投資平台。
作為上實集團旗下主動基金管理平台,上實資本自成立以來,立足上海、聯動香港、面向全球,積極探索生物醫藥、綠色環保等戰略新興產業的投資機遇。通過多幣種、全階段的基金矩陣佈局,深度服務國家戰略與生物醫藥高地建設。董事會衷心感謝大冢長期以來對公司的支持,並對上實資本旗下基金的加入表示熱切地期待。
董事會認為,上實資本將成為公司的重要戰略股東。依託其國資背景和產業資源,在符合市場規則和戰略協同的前提下,助力集團核心業務拓展及潛在戰略併購,追求更卓越的公司治理水平,為集團的持續創新、高質量發展與規模能級提升提供支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.